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Objectives: The outer membrane protein M35 of Moraxella catarrhalis is an antigenically conserved porin.
Knocking out M35 significantly increases the MICs of aminopenicillins. The aim of this study was to determine
the biological mechanism of this potentially new antimicrobial resistance mechanism of M. catarrhalis and the
behaviour of M35 in general stress situations.
Methods: PCR using m35-specific primers was used to detect the m35 gene in clinical isolates. The m35 mRNA
expression of strains 300, O35E and 415 after exposure to amoxicillin and different stress conditions was
measured by real-time PCR and normalized in relation to their 16S rRNA expression. The expression of M35
protein was analysed by SDS-PAGE and western blotting.
Results: Screening of 52 middle ear isolates resulted in positive PCR products for all tested strains. The analysis of
m35 mRNA expression after amoxicillin treatment showed 24%–85% down-regulation compared with the res-
pective amoxicillin-free controls in all three strains tested. Also, analysis of protein concentrations revealed lower
M35 expression after growth with amoxicillin. Investigation of M35 during general stress responses showed
down-regulation of the porin with growth at 268C and 428C, under hyperosmolar stress and under iron restriction.
Conclusions: The reducedexpressionofM35afteraminopenicillin exposure indicatesanovel resistancemechanism
against aminopenicillins inM. catarrhalis, whichmay be relevant in vivo. The differences in expression after different
stress treatments demonstrate that M35 is involved in general stress responses.
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Introduction
Moraxella catarrhalis is a Gram-negative diplococcus and an
exclusively human pathogen, mainly involved in exacerbations
of chronic obstructive pulmonary diseases (COPD) in adults and
acute otitis media in young children.1–5 The proportion of
cases of acute otitis media caused by M. catarrhalis varies
between 5% and 20%, with recent studies showing an increase
of M. catarrhalis-caused otitis media since the introduction of
routine infant immunization with pneumococcal conjugate
vaccine.2–4,6,7 Acute otitis media treated with standard or high-
dose amoxicillin is still the recommended therapeutic standard in
Europe as well as in the USA.8–11 Treatment failures after the use
of amoxicillin are documented in different studies and are
usually related to infections with b-lactamase-producing
strains of Haemophilus influenzae or M. catarrhalis or a
drug-resistant strain of Streptococcus pneumoniae.2,11–15 More
than 90% of M. catarrhalis isolated worldwide are resistant to
penicillin and until now the only known resistance mechanism
has been the production of one of two bro b-lactamases
(BRO-1 and BRO-2).2,16–19 We previously demonstrated that
M. catarrhalis strains lacking the outer membrane protein
(OMP) M35 display an MIC of aminopenicillins up to 3-fold
higher in comparison with their respective wild-types, indicating
that M35 is involved in the susceptibility of the organism to these
antimicrobials.20 M35 is a highly conserved porin in type 1 strains
of M. catarrhalis; it is involved in nutrient uptake, appears essen-
tial for nasal colonization in mice and results in a mucosal
immune response manifested as specific IgA in human
saliva.20–22 Porins are water-filled open channels in the outer
membrane of bacteria and allow the passive penetration of
hydrophilic molecules. They can be differentiated by their activity
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(non-specific or specific), their functional structure and their
regulation and expression pattern.23–27 By their function as
passive transport channels they are not only involved in the
uptake of nutrients but also of drugs such as antimicrobials.27,28
Therefore it is not surprising that one of the main antimicrobial
resistance strategies of bacteria is altered porin expression to
limit intracellular access of antibiotics. In particular, antimicrobial
resistance to b-lactam antibiotics is often described as a combi-
nation of the production of b-lactamases and altered porin
expression, which appears to be highly efficient.27–37 Not only
antimicrobials, however, induce alterations in porin expression,
but also general stressors, such as nutrient deprivation, tempera-
ture changes, osmolarity, pH changes and iron depletion.38–42
The major aim of this study was to determine the mechanism
by which M35 is involved in the susceptibility to aminopenicillins.
Secondarily, we observed M35 expression in response to general
bacterial stress factors.
Materials and methods
Bacterial strains and culture conditions
The M. catarrhalis strains and their isogenic m35 mutants used in this
study are listed in Table 1. All strains were cultured at 378C and 150–
200 rpm in brain heart infusion (BHI) broth (Difco, Detroit, MI, USA) or
on BHI agar plates in an atmosphere containing 5% CO2. Media were sup-
plemented with kanamycin (20 mg/L) for culturing of the mutants.
Escherichia coli DH5a was grown on Luria-Bertani (LB) agar plates or in
LB broth. For analysis of the effects of amoxicillin, bacteria were cultured
in BHI broth to an optical density (600 nm) (OD600) of 0.18. Afterwards,
60 mg/L amoxicillin (Sigma-Aldrich, Steinheim, Germany) was
added and bacteria were cultured for an additional 4 h. To quantify
viable M. catarrhalis at various amoxicillin concentrations, bacteria were
cultured at different concentrations (0, 6, 18, 60 mg/L) of the antibiotic
for 4 h, and both the OD600 and cfu were determined at different time-
points (Figure 1). For temperature experiments, bacteria were cultured
to an OD600 of 0.3 before exposing them to 268C, 428C or 378C, for 3 h.
M35 expression under hyperosmolar stress and iron depletion conditions
was analysed by adding 0.5 mol/L NaCl or 50 mM desferioxamine to the
BHI medium at a culture density (OD600) of 0.3.
DNA methods
Plasmids were isolated using the Wizard Plus SV Miniprep DNA purifi-
cation system (Promega, Madison, WI, USA). E. coli DH5a was trans-
formed as described previously.43 Restriction enzymes were purchased
from New England Biolabs (Beverly, MA, USA). Electrocompetent M. catar-
rhalis was prepared and DNA was electroporated as described.44 DNA
sequencing was performed using an ABI Prism 310 Genetic Analyzer
(PE Biosystems, Rotkreuz, Switzerland) with the BigDye Terminator Cycle
Sequencing Ready Reaction Kit (PE Biosystems). M. catarrhalis strains
1–52 (middle ear isolates provided by Prof. Ron Dagan, Beer-Sheva,
Israel) were analysed for the presence of m35 by PCR using forward
primer M35F3 (5′-CTTGCTCTAGCAACCGCAG-3′) and reverse primer
M35_R_MJ1 (5′-CGTAGCAGTTTTCATCTCACCAC-3′) and visualized by 1%
agarose gel electrophoresis.
b-Lactamase production testing and bro gene typing
Isolates were investigated for b-lactamase production by the nitrocefin
disc test (BD, Basel, Switzerland). b-Lactamase BRO typing was per-
formed by sequencing the putative promoter region of the bro gene,
described elsewhere, which shows clear sequence differences between
BRO-1 and BRO-2.19 DNA sequencing was performed using an ABI
Prism 310 Genetic Analyzer (PE Biosystems) with the BigDye Terminator
Cycle Sequencing Ready Reaction Kit (PE Biosystems). Sequences were
analysed with Lasergene software (DNASTAR, Madison, WI, USA). To
sequence the relevant bro gene region, DNA was amplified using the
primers bro_F_MJ (5′-TATCGCACCCCGTAGGACAA-3′) and bro_R_MJ
(5′-GTAAGGAATTGGTTTTGCGGTATC-3′).
RNA methods
RNA for m35 mRNA expression analysis was isolated and used for cDNA
synthesis as described elsewhere.45 Quantitative real-time PCR was per-
formed in triplicate for both target (m35) and normalizer [16S ribosomal
RNA (rRNA)] genes. No-template controls and reverse transcriptase-
negative controls were included in each run. Primers and probes for
m35 were purchased from Applied Biosystems (Rotkreuz, Switzerland).
The forward primer was M35ANYF (5′-GCCTTTGCTTATGTATCACCTGAGT-3′),
the reverse primer was M35ANYR (5′-GCATTGATAGGGCCTGTGCTA-3′) and
the TaqMan probe was 5′-(FAM)CACCCACACCAAACTG(TAMRA)-3′. Primers
and probes for 16S rRNA were used as described elsewhere.45,46 Relative
quantification of gene expression was performed using the comparative
threshold method. The ratios obtained after normalization were
expressed as fold changes compared with untreated samples.
Preparation of OMPs
OMPs were prepared by the EDTA buffer method as described.47 Bacteria
were harvested after amoxicillin or cold shock treatment, respectively, as
described, resuspended in EDTA buffer (0.05 M Na2HPO4, 0.15 M NaCl,
0.01 M EDTA, pH 7.4), homogenized and incubated at 558C at 300 rpm
Table 1. M. catarrhalis strains and their isogenic m35 mutants used in this study
Strain Description MIC (mg/L)20
b-Lactamase
production BRO type Reference or source
Isolates 1-52 middle ear isolates from children with acute otitis media not done not done not done Beer-Sheva, Israel
O35E parent strain; middle ear isolate 3 + BRO-1 71
O35E.m35 isogenic m35 mutant; kanamycin resistant 6 + BRO-1 this study
300 parent strain; nasopharyngeal isolate 6 + BRO-1 72,73
300.m35 isogenic m35 mutant; kanamycin resistant 16 + BRO-1 this study
415 parent strain; nasopharyngeal isolate 2 + BRO-1 72,73
415.m35 isogenic m35 mutant; kanamycin resistant 6 + BRO-1 this study
DH5a (E. coli) host strain for plasmid constructs not done not done not done 74
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for 1 h. Cells and cell debris were eliminated by centrifugation at 10000 g
for 15 min at 48C. Finally, OMPs were collected by ultracentrifugation at
100000 g for 2 h at 48C.
SDS-PAGE and immunoblot
Samples were resolved by SDS-PAGE using a 10% polyacrylamide gel. To
compare protein expression between treated and untreated samples, the
protein concentration loaded on the SDS-PAGE was always 1 mg/L. Band
intensity was quantified using the AlphaEaseFC program (Inotech, San
Leandro, CA, USA). Antibody detection was performed by western blot
analysis as described elsewhere.20 Proteins were transferred to polyviny-
lidene difluoride membranes (Immobilon-P; Millipore, Bedford, MA, USA).
IgA binding was detected using human saliva samples as the primary
antibody source and goat anti-human IgA labelled with horseradish per-
oxidase (Sigma) as the secondary antibody. SuperSignal West Pico Che-
miluminescent Substrate (Pierce Chemical, Rockford, IL, USA) was used
for detection of antibody binding. Unstimulated human saliva was col-
lected from healthy volunteers using Salivette sponges (Sarstedt, Nu¨m-
brecht, Germany), centrifuged for 5 min at 2000 rpm and stored at
2208C. All volunteers were laboratory researchers and provided oral
informed consent. Sampling of saliva from healthy volunteers was
approved by the local ethics committee. OMPs of m35 knockout
mutants were used as negative controls for their respective wild-type
strains. Construction of the isogenic mutants O35E.m35, 300.m35 and
415.m35 has been described elsewhere.20
Results
PCR analysis of 52 clinical isolates
Our previous findings of increased amoxicillin MIC form35 knock-
out mutants compared with their respective wild-type parent
strains prompted us to investigate the possibility of naturally
occurring clinical middle ear isolates lacking an m35 gene.20
We studied 52 middle ear isolates obtained from Prof. Ron
Dagan (Beer-Sheva, Israel). PCR resulted in positive products for
all 52 strains.
Down-regulation of m35 mRNA expression after
amoxicillin treatment
Reduced membrane permeability—one of the main strategies
used by bacteria for protection against antibiotics—is generally
regulated by altered porin expression.27,28 Consequently, we
investigated the m35 mRNA expression of strains 300, O35E
and 415 during amoxicillin treatment by quantitative real-time
PCR. The breakpoint of bactericidal amoxicillin concentration
was evaluated by a time–kill curve assay and was found to
be at 60 mg/L (Figure 1), which correlates with the MIC for
the wild-type strain 300 depending on the inoculum, which is
more than 10 times higher in this experimental setting than
in antimicrobial resistance testing using Etests.20 Growth
curves with 60 mg/L amoxicillin demonstrated that this concen-
tration seems not to be completely bactericidal but inhibits
growth for a period of 4 h before proliferation resumes (data
not shown). Compared with bacteria grown without amoxicillin,
strain 300 grown with 60 mg/L amoxicillin showed a decrease
of 85+2% in its m35 mRNA expression (Figure 2). Strain
O35E demonstrated a similar effect, i.e. 73.7+24% down-
regulation of m35 mRNA after amoxicillin treatment (data not
shown). In strain 415, down-regulation was only 24+9%. We
also observed down-regulation of m35 mRNA transcription in
strain 300 after treatment with a subinhibitory concentration
of amoxicillin (15 mg/L). This effect, however, was less pro-
nounced (33+5.6%) than with an amoxicillin concentration at
the MIC (data not shown).
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Figure 2. Down-regulation of m35 mRNA expression during amoxicillin
treatment. Quantitative real-time PCR was performed after 4 h of
incubation with and without 60 mg/L amoxicillin. Up- or down-regulation
was normalized to 16S rRNA. The graph shows one of three
representative experiments done in triplicate. Data are presented as
means+1 SD (n¼3).
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Figure 1. Time–kill curves of strain 300 for different amoxicillin concentrations (0, 3, 6, 18 and 60 mg/L). (a) OD600. (b) cfu/plate.
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M35 protein expression is also affected by amoxicillin
To determine that a reduction of mRNA copy number translates
into less M35 protein in the outer membrane, OMPs from bac-
teria grown with and without amoxicillin were isolated and
protein expression was analysed by SDS-PAGE and western
blotting. Strain 300 (Figure 3) as well as strains O35E and 415
(data not shown) expressed less M35 protein both on the SDS
gel (Figure 3) and in western blot analysis (Figure 3). These
data demonstrate that M. catarrhalis senses the presence of
amoxicillin in the medium and subsequently down-regulates
M35 porin expression.
b-Lactamase production and BRO typing
The investigation of the b-lactamase production of all three
strains and its m35 knockout mutants showed that all strains
produced b-lactamases. The sequences of the putative promoter
region of the bro gene were identical to those published by
Bootsma et al.19 and identified all our strains as BRO-1
b-lactamase producers.
Cold shock induces down-regulation of m35 mRNA
Porins involved in antimicrobial resistance have often been
described to take part in general stress responses.38–42 One of
the best known stress responses of M. catarrhalis is the cold
shock response, which alters the expression of specific OMPs
after exposure to 268C.45,48 In the course of our further studies,
and emphasizing that the expression of M35 appeared to be par-
ticularly stress-sensitive, we thus investigated the response of
m35 induced by general stress stimuli such as cold shock
treatment. Indeed, all three strains—O35E, 300 and 415—
showed an effect reminiscent of amoxicillin exposure in that
expression was down-regulated after growth at 268C in compari-
son with 378C. Strains O35E (Figure 4), 300 and 415 demon-
strated down-regulation of 76+4%, 57.6+3% (data not
shown) and 52.2+19%, respectively.
M35 protein expression is involved in the cold shock
response
To prove that down-regulation induced by cold shock is not only
a transcriptional event, OMPs from cold shock- and non-cold
shock-treated bacteria were isolated and analysed by
SDS-PAGE and western blotting. Indeed, M35 protein expression
was clearly down-regulated in strain O35E (Figure 5) as well as
in strains 300 and 415 (data not shown).
m35 mRNA expression is affected by general stress
conditions
Cold shock is not the only stress condition that affectsM. catarrha-
lis. Amongst others, heat shock, altered osmolarity and iron
depletion occur in their mucosal habitat. Thus, we analysed m35
mRNA expression under these conditions. The analysis revealed
m35 down-regulation after growth at 428C (66+29%), as well
as in response to hyperosmolar stress (86+14%) and iron
depletion (56.3+22%) (Figure 6). Taken together, these data indi-
cate that the level of m35 is influenced by various environmental
variables, which may consequently affect susceptibility to amino-
penicillins in the mucosal habitat of the respiratory tract.
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Figure 3. SDS-PAGE (a) and western blot (c) of M. catarrhalis OMPs (1 mg/L) from strain 300 after growth with and without 60 mg/L amoxicillin
together with its respective m35 knockout mutant as the negative control. The rectangle shows the position of the M35 protein band at 36 kDa.
(b) The spectra display the intensity of each SDS-PAGE protein band from strain 300 grown without amoxicillin and with 60 mg/L amoxicillin
proportional to the total protein intensity.
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Discussion
Antimicrobial resistance is based on three major strategies:
detoxifying enzymes to degrade or modify antibiotics; target pro-
tection to impair target recognition and thus antimicrobial
activity; and the membrane barrier to limit intracellular access
of antimicrobials.49 For M. catarrhalis, until now just one of
these three strategies has been described—the production of
two different chromosomal b-lactamases.16 More than 95% of
clinical isolates are resistant to penicillin and it was shown
recently that 80% of all strains tested in the UK and Ireland
were resistant to cefaclor and 5% to cefuroxime.16,50–54 Drug
resistance to b-lactam antibiotics is often associated with a
second major resistance strategy—reduced outer membrane
permeability.23,26,27,49,55 Reduced membrane permeability can
be the result of altered porin expression or the presence of a
mutated porin.23,26–28,49,55
Our analysis of 52 clinical middle ear isolates using PCR ampli-
fication with conserved primers failed to identify strains lacking
an m35 gene on their chromosome. This finding corroborates
previous data indicating that m35 is a highly conserved porin
gene and indicates that in vitro aminopenicillin susceptibility
must be mediated by means other than lack of porin
expression.21 Easton et al.21 demonstrated that M35 is structu-
rally homologous to classical Gram-negative porins, such as
OmpC from E. coli and OmpK36 (OmpC homologue) from
Klebsiella pneumoniae. Both porin types are involved in anti-
microbial resistance mechanisms and are described in detail
elsewhere.27,28 Several investigators have shown altered porin
expression during antibiotic therapy, resulting in specific
antimicrobial resistances, dependent on the ability of the
bacteria to produce b-lactamase, their general porin compo-
sition and the antimicrobial substance they are confronted
with.27–29,33,34,36,37,56,57 Our findings of the down-regulation of
M35 expression at the transcriptional level as well as at the
protein level in all three b-lactamase-producing strains tested,
together with our previous observations of the significantly
higher aminopenicillin MICs for the M35 knockout mutants, indi-
cate that we have found a potentially novel resistance mechan-
ism against aminopenicillins in M. catarrhalis.20 The MICs of
ampicillin and amoxicillin for the M35 knockout strains were up
to 3-fold greater than for their respective wild-type strains,
and even amoxicillin/clavulanate displayed the same effect.20
The mechanism seems to be similar to those described for
K. pneumoniae OmpK36 and Omp36 porin (OmpC homologue)
from Enterobacter aerogenes.27,28,33,34,37,56,56–62 Down-regulation
of OmpK36 leads, depending on which b-lactamase the isolate is
producing, to resistance to oxyimino and zwitterionic cephalo-
sporins or carbapenems.59–62 In E. aerogenes, loss of Omp36
leads mainly to imipenem resistance.56 This demonstrates an
additional analogy to our findings. The specificity for aminopeni-
cillins—which are also zwitterionic molecules—is reminiscent of
the physical characteristics of OmpK36 and Omp36.63,64 Never-
theless, the differences between the down-regulation of M35
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Figure 5. SDS-PAGE (a) and western blot (c) of M. catarrhalis OMPs (1 mg/L) from strain O35E after growth at 268C compared with 378C together with
its respective m35 knockout mutant as the negative control. The rectangle shows the position of the M35 protein band at 36 kDa. (b) The spectra
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Figure 4. Down-regulation of m35 mRNA expression after cold shock
exposure. Quantitative real-time PCR was performed after 3 h of
incubation at 268C or 378C. Up- or down-regulation was normalized to
16S rRNA. The graph shows one of three representative experiments
done in triplicate. Data are presented as means+1 SD (n¼3).
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after amoxicillin treatment between strain O35E and 415 with
the same MICs for wild-type and mutants, respectively, indicate
that there must be a regulation mechanism whose complexity
exceeds b-lactamase production and protein down-regulation.20
The bacterial stress response is based on a complex network
of regulatory systems—a cascade of alterations in gene
expression and protein activity that favour survival under
extreme and rapidly changing conditions.39,65 Porins, especially
those involved in antimicrobial resistance, such as those of the
OmpF and OmpC-like porin families, are often reported to be
associated with general stress responses.40–42 Cold shock as
well as heat shock responses are well known mechanisms and
have been researched intensively in E. coli and Bacillus
subtilis.40,42,66,67 We have shown previously that the cold
shock response is obviously an important mechanism for
M. catarrhalis as an adaptation and survival mechanism in the
nasopharyngeal habitat, but also regarding its virulence and
colonization abilities.45,48,68 Begic and Worobec42 showed that
temperature is also a predominant effector of expression regu-
lation of OmpF and OmpC in Serratia marcescens. This organism
is a b-lactam-resistant Gram-negative bacterium, whose
porins—OmpF and OmpC—show high similarities to those of
E. coli and are also involved in b-lactam resistance by decreasing
outer membrane permeability.38,42,69,70 By analysing the regu-
lation of these porins, these authors showed that OmpF is
up-regulated and OmpC is down-regulated after growth at
288C, but the opposite way round after growth at 428C.42 The
same effect of OmpC regulation, comparable to our findings in
M35 after cold shock treatment (Figures 4 and 5), has been
described in E. coli several times.40–42 M35 down-regulation
after exposure to 428C has not been described until now. The
general effect described in all Gram-negative bacteria is
up-regulation of the OmpC-like protein after heat shock treat-
ment, whereas OmpF is down-regulated. However, antagonistic
regulation of OmpF and OmpC is apparently not the general
mechanism in all E. coli strains.40,42 Allen et al.41 observed down-
regulation of both OmpF and OmpC after cold shock treatment in
E. coli O157:H7. Certainly, the physiological basis for porin regu-
lation under temperature stress conditions is still unclear and
needs further investigation. Likewise, our findings concerning
the down-regulation of M35 under high osmolarity conditions
need further scrutiny. Generally, the OmpC-like porin is down-
regulated at low osmolarities and up-regulated at high osmolar-
ity conditions—similar to our findings under temperature stress
conditions.40,42 However, it is currently not known whether
M. catarrhalis possesses an OmpF-like porin acting as an M35
antagonist. It is conceivable that M. catarrhalis expresses only
the OmpC-like porin M35 comparable to K. pneumoniae strains
expressing extended-spectrum b-lactamase (ESBL). These
ESBL-expressing strains produce only the OmpC-like porin
OmpK36.34,58 This could explain—together with the high speci-
ficity of molecule transport—why the role of M35 in stress
response regulation is clearly different from that of OmpC-like
porins associated with an antagonist. The expression of an
OmpC-like porin in response to iron depletion has, to our knowl-
edge, also never been described before, but substantiates the
notion that the regulation of M35 is an important mechanism
allowing the survival of M. catarrhalis under changing environ-
mental conditions.
In summary, we describe here a new antimicrobial resistance
mechanism in M. catarrhalis against aminopenicillins, which
obviously could lead to significantly higher MICs that would
affect the use of amoxicillin in the therapy of acute otitis
media caused by M. catarrhalis in a critical manner.20 To verify
these findings in vivo and clarify its clinical relevance regarding
amoxicillin therapy of acute otitis media caused by M. catarrhalis,
further analyses will be needed. In particular, it will be necessary
to elucidate whether down-regulation of M35 during treatment
may contribute to treatment failure caused by isolates that
have been shown to be susceptible in vitro.
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